Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| May 19, 2010 | VP, Pharmacology & Biology | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 19, 2010 | VP, Pharmacology & Biology | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 19, 2010 | VP, Pharmacology & Biology | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 19, 2010 | VP, Pharmacology & Biology | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 19, 2010 | VP, Pharmacology & Biology | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 19, 2010 | VP, Pharmacology & Biology | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 19, 2010 | VP, Pharmacology & Biology | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.